Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation

Journal of Critical Care

Volumn 29, Issue 2, 2014, Pages 265-271

  Khadzhynov, Dmytro ^a   Schelter, Christin ^a   Lieker, Ina ^a   Mika, Alice ^a   Staeck, Oliver ^a   Neumayer, Hans H ^a   Peters, Harm ^a   Slowinski, Torsten ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute renal injury; Citrate accumulation; Citrate anticoagulation; Continuous renal replacement therapy; Continuous venovenous hemodialysis; Lactate acidosis

Indexed keywords

BICARBONATE; CALCIUM; CALCIUM ION; CITRIC ACID; FRESH FROZEN PLASMA; GLUCONATE CALCIUM; LACTIC ACID; OXYGEN; TROMETAMOL; ANTICOAGULANT AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGE; AGED; ANTICOAGULATION; APACHE; ARTICLE; ARTIFICIAL KIDNEY; CELL HYPOXIA; CELL RESPIRATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTINUOUS HEMODIALYSIS; CRITICALLY ILL PATIENT; DIET SUPPLEMENTATION; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HYPOCALCEMIA; INCIDENCE; INTENSIVE CARE UNIT; LACTIC ACIDOSIS; MALE; METABOLIC ACIDOSIS; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PH; PROGNOSIS; REGIONAL CITRATE ANTICOAGULATION; RETROSPECTIVE STUDY; SEX RATIO; SHOCK; SURVIVAL RATE; ACUTE KIDNEY INJURY; BLOOD; CRITICAL ILLNESS; METABOLIC DISORDER; RENAL REPLACEMENT THERAPY;

ACUTE KIDNEY INJURY; AGED; ANTICOAGULANTS; CALCIUM; CITRATES; CITRIC ACID; CRITICAL ILLNESS; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC DISEASES; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES;

EID: 84896700954     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.10.015     Document Type: Article

References (30)

1. KDIGO AKI Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012, 2(1):1-138.
2. Wu M.Y., Hsu Y.H., Bai C.H., Lin Y.F., Wu C.H., Tam K.W. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis 2012, 59(6):810-818.
3. Zhang Z., Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med 2012, 38(1):20-28.
4. Joannidis M., Oudemans-van Straaten H.M. Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care 2007, 11(4):218.
5. Mariano F., Bergamo D., Gangemi E.N., Hollo Z., Stella M., Triolo G. Citrate anticoagulation for continuous renal replacement therapy in critically ill patients: success and limits. Int J Nephrol 2011, 2011:748320.
6. Faybik P., Hetz H., Mitterer G., Krenn C.G., Schiefer J., Funk G.C., et al. Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system. Crit Care Med 2011, 39(2):273-279.
7. Slowinski T., Morgera S., Joannidis M., Kindgen-Milles D. Multicenter prospective observational study on safety and efficacy of regional citrate anticoagulation in CVVHD in the presence of liver failure: the Liver Citrate Anticoagulation Threshold Study (L-CAT). Crit Care 2011, 15(Suppl. 1):127.
8. Oudemans-van Straaten H.M., Kellum J.A., Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy-heparin or citrate?. Crit Care 2011, 15(1):202.
9. Meier-Kriesche H.U., Gitomer J., Finkel K., DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001, 29(4):748-752.
10. Oudemans-van Straaten H.M. Citrate anticoagulation for continuous renal replacement therapy in the critically ill. Blood Purif 2010, 29(2):191-196.
11. Morgera S., Schneider M., Slowinski T., Vargas-Hein O., Zuckermann-Becker H., Peters H., et al. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 2009, 37(6):2018-2024.
12. Hetzel G.R., Taskaya G., Sucker C., Hennersdorf M., Grabensee B., Schmitz M. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis 2006, 48(5):806-811.
13. Meier-Kriesche H.U., Finkel K.W., Gitomer J.J., DuBose T.D. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis 1999, 33(4):e8.
14. Kramer L., Bauer E., Joukhadar C., Strobl W., Gendo A., Madl C., et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003, 31(10):2450-2455.
15. Kutsogiannis D.J., Gibney R.T., Stollery D., Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005, 67(6):2361-2367.
16. Oudemans-van Straaten H.M., Bosman R.J., Koopmans M., van der Voort P.H., Wester J.P., van der Spoel J.I., et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009, 37(2):545-552.
17. Hetzel G.R., Schmitz M., Wissing H., Ries W., Schott G., Heering P.J., et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011, 26(1):232-239.
18. Mariano F., Tedeschi L., Morselli M., Stella M., Triolo G. Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients. Intensive Care Med 2010, 36(10):1735-1743.
19. Kalb R., Kram R., Morgera S., Slowinski T., Kindgen-Milles D. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk. Ther Apher Dial 2013, 17(2):202-212.
20. Morabito S., Pistolesi V., Tritapepe L., Zeppilli L., Polistena F., Strampelli E., et al. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution. Crit Care 2012, 16(3):R111.
21. Link A., Klingele M., Speer T., Rbah R., Poss J., Lerner-Graber A., et al. Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Crit Care 2012, 16(3):R97.
22. Piednoir P., Allou N., Provenchere S., Berroeta C., Huisse M.G., Philip I., et al. Heparin-induced thrombocytopenia after cardiac surgery: an observational study of 1,722 patients. J Cardiothorac Vasc Anesth 2012, 26(4):585-590.
23. Spencer F.A. Heparin-induced thrombocytopenia: patient profiles and clinical manifestations. J Thromb Thrombolysis 2000, 10(Suppl 1):21-25.
24. Bakker A.J., Boerma E.C., Keidel H., Kingma P., van der Voort P.H. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Clin Chem Lab Med 2006, 44(8):962-966.
25. Moseley R.H. Sepsis and cholestasis. Clin Liver Dis 2004, 8(1):83-94.
26. O'Grady J.G., Alexander G.J., Hayllar K.M., Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989, 97(2):439-445.
27. Chadha V., Garg U., Warady B.A., Alon U.S. Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 2002, 17(10):819-824.
28. Swartz R., Pasko D., O'Toole J., Starmann B. Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Clin Nephrol 2004, 61(2):134-143.
29. James M.F., Roche A.M. Dose-response relationship between plasma ionized calcium concentration and thrombelastography. J Cardiothorac Vasc Anesth 2004, 18(5):581-586.
30. Calatzis A., Toepfer M., Schramm W., Spannagl M., Schiffl H. Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron 2001, 89(2):233-236.